BHCBausch Health Companies Inc.
$6.04-10% 1Y
$6.04
$4.4452 weeks$7.90
The financials
Bausch Health Companies Inc. by the numbers
Bausch Health Companies Inc. (BHC) reported revenue of $2.85B in Q2 2026 (quarter ended Jun 30, 2026), up 13% from the same quarter a year earlier. That came with net income of $260M (9.1% of revenue). For the full year FY2025, revenue was $10.3B (+6.7% year on year) and net income $120M. Its largest region in Q4 2024 (quarter ended Dec 31, 2024) was United Statesand Puerto Rico at $1.54B, 60% of the disclosed total, well ahead of Other Countries at 11%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.85B | $2.53B | +13% |
| Operating income | $740M | $444M | +67% |
| Net income | $260M | $128M | +103% |
| Diluted EPS | $0.68 | $0.40 | +70% |
| Geographic | Revenue | Share |
|---|---|---|
| United Statesand Puerto Rico | $1.54B | 60% |
| Other Countries | $292M | 11% |
| China | $145M | 5.7% |
| Canada | $109M | 4.3% |
| Poland | $94M | 3.7% |
| Mexico | $67M | 2.6% |
| France | $52M | 2.0% |
| Japan | $52M | 2.0% |
| South Korea | $44M | 1.7% |
| Russia | $44M | 1.7% |
| United Kingdom | $35M | 1.4% |
| Germany | $34M | 1.3% |
| Spain | $28M | 1.1% |
| Italy | $23M | 0.9% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q4 2024Total $2.56B (+2.0%)
South Korea grew +83% year on yearMexico -24% year on year
Segment Latestquarter on quarteryear on year
- United States and Puerto Rico$1.54B$1.54Bquarter on quarter +0.33%year on year +5.8%+0.33%+5.8%
- Other Countries$292.0M$292.0Mquarter on quarter +11%year on year +4.7%+11%+4.7%
- China$145.0M$145.0Mquarter on quarter +9.8%year on year +15%+9.8%+15%
- Canada$109.0M$109.0Mquarter on quarter +4.8%year on year +11%+4.8%+11%
- Poland$94.0M$94.0Mquarter on quarter +2.2%year on year +8.0%+2.2%+8.0%
- Mexico$67.0M$67.0Mquarter on quarter -24%year on year -24%-24%-24%
- France$52.0M$52.0Mquarter on quarter 0.00%year on year +16%0.00%+16%
- Japan$52.0M$52.0Mquarter on quarter +13%year on year +6.1%+13%+6.1%
- South Korea$44.0M$44.0Mquarter on quarter +16%year on year +83%+16%+83%
- Russia$44.0M$44.0Mquarter on quarter +4.8%year on year +2.3%+4.8%+2.3%
- United Kingdom$35.0M$35.0Mquarter on quarter +2.9%year on year +6.1%+2.9%+6.1%
- Germany$34.0M$34.0Mquarter on quarter -15%year on year +3.0%-15%+3.0%
- Spain$28.0M$28.0Mquarter on quarter +33%year on year +12%+33%+12%
- Italy$23.0M$23.0Mquarter on quarter 0.00%year on year +4.5%0.00%+4.5%
Drug Manufacturers, Specialty & Generic
Ranks #13 of 41 by RyuScore